Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis-Reference-Cited by-同舟云学术

Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis

Published:2012-02 Issue:3 Volume:196 Page:193-197
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Reid Christopher M¹,Ademi Zanfina¹²,Nelson Mark R³,Connor Greg⁴,Chew Derek P⁵,Shiel Louise¹,Smeath Ana⁶,Looze Fred⁷,Steg Ph Gabriel⁸,Bhatt Deepak L⁹,Liew Danny²

Affiliation:

1. CCRE Therapeutics, Monash University, Melbourne, VIC.

2. Melbourne EpiCentre, University of Melbourne, Melbourne, VIC.

3. Discipline of General Practice, University of Tasmania, Perth, TAS.

4. Cardiovascular Diagnostic Services, Sydney, NSW.

5. Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, SA.

6. Sanofi‐aventis, Sydney, NSW.

7. Department of General Practice, University of Queensland, Brisbane, QLD.

8. Coronary Care Unit, Bichat Public Hospital, Paris, France.

9. Brigham and Women's Hospital and Harvard Medical School, Boston, Mass, USA.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja11.10731

Reference28 articles.

1. Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

2. Economic implications of obesity among people with atherothrombotic disease

3. Identifying men at high risk of heart attacks: strategy for use in general practice.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta‐analysis;Nephrology;2021-06-28

2. Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029;European Journal of Preventive Cardiology;2021-03-04

3. Peripheral artery disease patients are poorly aware of their disease;Scandinavian Cardiovascular Journal;2019-07-24

4. Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study;Heart, Lung and Circulation;2019-06

5. Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective;European Journal of Preventive Cardiology;2018-12-10